Ige Production
Ige Production - Related Videos
09:40
Detection of True IgE-expressing Mouse B Lineage Cells
0 Views •
Cited by 3 •
2014
In vitro analysis of class switch recombination in mice is challenging due to cytophilic IgE molecules bound to Fc receptors on the surface of B cells. We describe a method for IgE detection using trypsin-mediated cleavage of surface-bound IgE prior to fixation and permeabilization for cytoplasmic fluorescence staining.
10:22
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
0 Views •
Cited by 14 •
2011
Basophil activation test is a potent tool for the detection of IgE-dependent allergies in vitro. Here, an optimized protocol for basophil activation test is used to investigate drug hypersensitivity. A method for the efficient production of covalent drug-protein conjugates and their physicochemical characterization is described.
01:25
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
0 Views •
2024
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed. Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
07:31
Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI
0 Views •
Cited by 16 •
2014
The current study describes the development and applications of a genetically engineered assay system based on the transfection of rat basophilic leukemia cells with the equine FcεRIα gene. Transfected cells express a functional receptor where the release of mediators of the allergic response can be activated by IgE and antigen.
11:42
Lentivirus Production
0 Views •
Cited by 43 •
2009
To make lentiviruses, DNA vectors are transfected into human 293 cells. After harvest and concentrating the supernatant, virus titer is determined by fluorescence expression with a flow cytometer.
FAQs
CD40 signaling and cytokines such as interleukin-4 (IL-4) or interleukin-13 (IL-13) provide the activation context for switching toward IgE. A B cell does not simply release a new antibody after exposure; it changes antibody class and can then differentiate into a plasma cell. This sequence links antigen recognition to subsequent antibody secretion.
Class-switch recombination moves B cells from producing another antibody class to producing IgE. The process is followed by differentiation into antibody-secreting plasma cells, which supplies the cellular source of secreted antibody. Studying these linked stages helps researchers distinguish signals that promote the switch from those associated with later antibody production.
Secreted IgE binds with high affinity to FcεRI receptors on mast cells and basophils. This binding leaves those cells primed to respond rapidly if the same antigen is encountered again. The receptor-associated stage therefore connects antibody production with later mediator release, making it central to research on IgE-mediated inflammation.
IgE participates in defense against parasites, but the same immune pathway can also drive allergic diseases. Its clinical significance depends on the outcome associated with antigen exposure and subsequent cellular activation. This dual role explains why IgE production is studied in both protective immunity and conditions involving unwanted inflammation.
Clinical research on IgE production addresses allergy, asthma, and anaphylaxis, while also considering immunodeficiency. These conditions provide different contexts for examining antibody generation, FcεRI-associated cellular priming, and mediator release. Comparing them can help investigators relate the pathway to disease mechanisms and identify which stages are most relevant to clinical investigation.
Mapping the pathway identifies clinically relevant points from B-cell signaling through IgE binding on mast cells and basophils. This information supports targeted therapies designed to reduce IgE-mediated inflammation. The approach is particularly relevant when researchers seek to connect a defined immune mechanism with outcomes in allergic disease, asthma, or anaphylaxis.